[EN] BENZIMIDAZOLONE DERIVATIVES AS BROMODOMAIN INHIBITORS<br/>[FR] DÉRIVÉS DE BENZIMIDAZOLONE EN TANT QU'INHIBITEURS DE BROMODOMAINE
申请人:GILEAD SCIENCES INC
公开号:WO2014160873A1
公开(公告)日:2014-10-02
This application relates to chemical compounds which may act as inhibitors of, or which may otherwise modulate the activity of, a bromodomain-containing protein, including bromodomain-containing protein 4 (BRD4), and to compositions and formulations containing such compounds, and methods of using and making such compounds. Compounds include compounds of Formula (I) wherein R1a, R1b, R2a, R2b, R3, and X are described herein.
The first electrochemical transition-metal-catalyzed meta-C−H functionalization has been accomplished, affording the positionally selective bromination product in an undivided cell by the catalysis of readily available RuCl3⋅3 H2O with aqueous HBr as the brominating agent.
第一个电化学过渡金属催化的间位-C−H 官能化已经完成,通过容易获得的 RuCl 3 ⋅3 H 2 O 和水性 HBr 作为溴化剂的催化作用,在未分割的电池中提供了位置选择性的溴化产物。